Viking Therapeutics: Strategic Positioning and Promising Development of Oral 2735 Drive Buy Rating

TipRanks17:58 ET · Ratings

Positive Outlook for Viking Therapeutics Amid Promising Trial Developments

TipRanks17:56 ET

Viking Therapeutics' Oral-2735 Could Differentiate Asset, Says JPMorgan

TipRanks17:55 ET

This Insider Has Just Sold Shares In Viking Therapeutics

Simply Wall St13:19 ET

Viking Therapeutics Analyst Ratings

Benzinga11:25 ET · Ratings

H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102

Moomoo NewsJan 8 10:33 ET · Ratings